Team:LCG-UNAM-Mexico/Notebook/2008-June 2

From 2008.igem.org

(Difference between revisions)
 
Line 124: Line 124:
         </tr>
         </tr>
         <tr>
         <tr>
-
<td class="bodyText"><div align="justify"><p><strong>Final design</strong></p>
+
<td class="bodyText"><div align="justify"><p><strong><u>Final design</u></strong></p>
<p>Scheme</p>
<p>Scheme</p>
<p><div id="pbfw">
<p><div id="pbfw">
Line 620: Line 620:
         </tr>
         </tr>
         <tr>
         <tr>
-
<td class="bodyText"><div align="justify"><p><strong>MODELING:</strong><br>
+
<td class="bodyText"><div align="justify"><p><strong><u>MODELING:</u></strong><br>
   <strong id="j4px695"><img src="http://docs.google.com/File?id=dntmktb_59hmv4brc3_b" alt="" name="graphics3" width="255" height="289" hspace="13" border="0" align="left" id="j4px696" /></strong><br><strong>Variables</strong> <br>
   <strong id="j4px695"><img src="http://docs.google.com/File?id=dntmktb_59hmv4brc3_b" alt="" name="graphics3" width="255" height="289" hspace="13" border="0" align="left" id="j4px696" /></strong><br><strong>Variables</strong> <br>
     Concentrations of:</p>
     Concentrations of:</p>
Line 699: Line 699:
         </tr>
         </tr>
         <tr>
         <tr>
-
<td class="bodyText"><div align="justify"><p><p><strong>WET LAB:</strong></p>
+
<td class="bodyText"><div align="justify"><p><p><strong><u>WET LAB:</u></strong></p>
<p>1. Take the sequences (fasta format) <br />
<p>1. Take the sequences (fasta format) <br />
   2. Once you have the sequence find appropriate reading frames <br />
   2. Once you have the sequence find appropriate reading frames <br />

Latest revision as of 01:12, 29 October 2008

LCG-UNAM-Mexico:Notebook/June_2

Header image
iGEM 2008 TEAM
line decor
  
line decor

 
 
 
 
 
 
June

2008-06-18

Final design

Scheme


The first plasmid contains the efflux pump for Nickel (RcnA), which will maintain its natural regulation dependent of RcnR and additionally, it will contain a promoter regulated by the repressor of lambda phage, cI as well as a resistance as a marker of the plasmid.

The second plasmid contains everything needed for regulating RcnA dependent on an external signal (AHL). Both luxR and aiiA will be synthesised constitutively. LuxR with a strong promoter (pTetR), as we do not want the presence of LuxR to be limiting and aiiA under the control of a moderate or weak promoter (pLacZ) for it is a very efficient enzyme, and we don't want it to degrade all AHL and prevent the signal from being transmitted. And cI*, which is a version of cI tagged with an LVA tail for rapid degradation, regulated by a promoter dependent of LuxR + AHL. It will also contain a resistance as a marker.

When AHL is added, it will bind LuxR and stimulate the production of cI*, which in turn will represses the transcription of rcnA. Like cI*, the signal produced by AHL will be short-lived since aiiA will be degradating it constantly, so the system quickly returns to its initial state.

Parts
Defining bioparts we will use or where to get what is necessary.

  • Part: BBa_I729006
  • Part of Quorum sensing used by the team Chiba in iGEM2007. Both tetR and LacI + pL are constitutive promoters, but since LacI + pL is a very strong promoter, it will probably be replaced. This biopart will be responsible for the regulation by luxR and the action of the system by AHL. Instead of GFP (Subpart E0040), the BBa_C0051 part that codes for the protein cI + LVA will be inserted, which will join the regulatory region of cI (biopart BBa_R0051) in the other plasmid.

    (Previous experience: none)


  • Part:BBa_C0051
  • Region coding for the repressor cI, of lambda phage, tagged with an LVA tail for rapid degradation. cI joins the regulator cI (BBa_R0051)

    (Previous experience: none)


  • Part:BBa_R0051
  •  

    Promoter regulated by cI based on the pR promoter of lambda phage. The promoter has two binding sites for the cI repressor of lambda phage (BBa_C0051). The binding of cI leads to the suppression of the transcript synthesis.

    (Previous experience: it works)

    The sequence of the 3 previously mentioned bioparts is in the Registry of Standard Biological Parts and according to the information provided by the registry, DNA is available.


  • Part: BBa_G00510
  • gatttctgcatagccagacttggg

    This is the forward primer for C0051, 24 bp long.


  • Part: BBa_G00511
  • cactgactagcgataactttccccac

    Reverse primer for C0051, 26 bp long.


    Vectors

    Possibilities in bioparts:

    Name
    Description
    pSB3C5 Low to medium copy BioBrick standard vector
    pSB3T5 Low to medium copy BioBrick standard vector
    pSB4A3 pSB4A3
    pSB4C5 Low copy BioBrick standard vector
    pSB4A1 pSB4A1
    pSB4A5 Low copy BioBrick standard vector
    pSB4T5 Low copy BioBrick standard vector
    BBa_I739202 pCK01BB1

    Primers

    Build or find oligos that we could use for our constructions.

    We need:
    • rcnA (with its regulatory region; no promoter).
    • cI* with its AHL-LuxR dependent promoter.
    • LuxR with its constitutive tetR promoter.
    • AiiA with its constitutive promoter (lac is proposed, it is a moderate promoter).
    • Promoter dependent of cI.
     In all cases, we have to check whether they already exist (in bioparts or elsewhere) and evaluate them.

     

     

    Sequence

    Tm

    Deg.

    Restr. Site

    Bioparts

    (pTetR)luxR/(p.c.strong)aiiA

    Upper

     

    62.5 ºC

    1

    None

    ?

    Lower

     

    63.8 ºC

    1

    None

    ?

    pcI

    Upper

     

    61.9-76.2 ºC

    864

    None

    ?

    Lower

     

    66.5 ºC

    1

    None

    ?

    pLacZ

    Upper

    5' GCACCCAGGCTTTACACTTT 3'

    64.7 ºC

    1

    None

    ?

    Lower

    5' TGTTATCCGCTCACAATTCCA 3'

    60.3 ºC

    1

    None

    ?

    cI*

    Upper

    5' GATTTCTGCATAGCCAGACTTGGG 3'

    62.9 ºC

    1

    None

    BBa_G00510

    Lower

    5' CACTGACTAGCGATAACTTTCCCCAC 3'

    61.9 ºC

    1

    None

    BBa_G00511

    rcnA

    Upper

    5' CACTATTAATCTACTGGGGGGTAG3'

    64.2ºC

    1

    None

     

    Lower

    5' AGTTATCGCATTATGCCCATG 3'

    65.8ºC

    1

    None

     


    Promoters

    Investigate more about the proposed promoters and define if they are the most optimal depending on our needs.

    Promoter

    Biopart

    Constitutive?

    Strength

    Notes

    pTetR

    BBa_R0040

    In tetracycline presence or TetR absence

    medium

    Recomended by our advisor Miguel

    pLuxR-HSL

    BBa_R0062

    Over-regulated by LuxR-HSL (increases its expression).

    weak (constitutive)/medium (LuxR-HSL)

    luxR could bring some trouble if it becomes a part of the sistem

    pLacIQ

    BBA_I14032

    Yes

    high

    ¿Is there a biopart? It could be the promoter for luxR

    pCyc

    BBa_I766555

    Yes

    medium

    Yeast promoter

    J23112

    BBa_J23113

    Yes

    1

     

    J23103

    BBa_J23113

    Yes

    17

     

    J23113

    BBa_J23113

    Yes

    21

     

    J23109

    BBa_J23113

    Yes

    106

     

    J23117

    BBa_J23113

    Yes

    162

     

    J23114

    BBa_J23113

    Yes

    256

     

    J23115

    BBa_J23113

    Yes

    387

     

    J23116

    BBa_J23113

    Yes

    396

    Constitutive promoters family

    J23105

    BBa_J23113

    Yes

    62

    J23110

    BBa_J23113

    Yes

    844

     

    J23107

    BBa_J23113

    Yes

    908

     

    J23106

    BBa_J23113

    Yes

    1185

     

    J23108

    BBa_J23113

    Yes

    1303

     

    J23118

    BBa_J23113

    Yes

    1429

     

    J23111

    BBa_J23113

    Yes

    1487

     

    J23101

    BBa_J23113

    Yes

    1791

     

    J23104

    BBa_J23113

    Yes

    1831

     

    J23102

    BBa_J23113

    Yes

    2179

     

    J23100

    BBa_J23113

    Yes

    2547

     

    Facts about kinetics & other things...

    Investigate more about the elements of the system to begin building an outline for the model and defining if design is theoretically feasible.

    NOTES: For LuxR to bind HSL and enable the transcription of cI, HLS should be at a micromolar concentration.
    Not all bioparts have been previously used, most DNA is available but there is still no record their functionality. We need to evaluate the DNA quality to ensure that there will be no problems.

    2008-06-24

    MODELING:

    Variables
    Concentrations of:

  • LuxR (constant).
  • aiiA (constant).
  • AHL (arbitrary).
  • cI* (according to aiiA, AHL & LuxR).
  • RcnA (according to cI*).
  • We need to determine the initial concentrations and lifetime of proteins involved, as well as the efficiency of AiiA (kinetics in general).
    The concentration of Nickel (NiCl2) in the medium that the cells can tolerate according to Rodrigue et al. (2005) before inhibiting growth is 4 μ M for the strain lacking rcnA, 10 μM in the wildtype and up to 100-fold more in a strain with a multicopy gene.


     

     

    Concentration

    Life span (half-life)

    Substrate affinity

    Notes

    AHL

    ?

    3 hrs.

    ?

    Conflictive information

    LuxR

    ?

    60 min- (~40-100)

    ?

     

    2 min (35 min +AHL)

     

    aiiA

    ?

    24 hrs

    ?

     

    cI*

    ?

    ?

    ?

     

    RcnA

    ?

    ?

    ?

     

    Assumption 1: Once there is nickel in the medium, RcnR will not interfere in the pump regulation. This because there will be large concentrations of metal, so we can assume that RcnR will always be bound to a molecule of nickel and it will therefore be unable to suppress the transcription of rcnA; the noise that the few RcnR free molecules can cause, will be indistinguishable from normal behaviour of the pump.

    Assumption 2: Any decrease in the concentration of AHL is due to aiiA. It is believed that the natural degradation of this molecule is irrelevant in the time scale analysis. Either way, a process will not be distinguishable from the other and even when the first is estimated, it would not be very informative for the analysis, so we intend to take this assumption as true.

    Assumption 3: The transcription of cI* depends solely on the concentration of AHL. LuxR is not a limiting step, ie, it is in a constant concentration and in sufficient amount to always be ready to associate with AHL. Only to simplify the analysis, at least for our first approach.

    Initial outline:

    (v1) AHL0
    (v2) aiiA + AHL -> aiiA
    (v3) AHL + LuxR -> cI*
    (v4,v5) ρ + cI* <--> ρ.cI*
    ρ -> ρ +RcnA
    RcnA + Ni -> RcnA
    RcnA -> Ø

     

    2008-06-26

    WET LAB:

    1. Take the sequences (fasta format)
    2. Once you have the sequence find appropriate reading frames
    3. Make the restriction map
    -- Nedcutter, check the page for NewEngland Biolabs (because we are going to use enzymes from that company)
    For rcnA and rcnR, the regulatory region that was among the two genes was not explained.
    We have to take the whole sequence in fasta format and use it in a program called Gene Construction Kit. This shows reading frames and restriction sites.

     

    In fruitfly.org: 9005/seq_tools/promoter.html we can look for primers and we can adjust parameters. We can also analyze the stability energy, and seek the lowest point of stability. This point is generally the -10box. To find inverted repeats, we shall use the program StemLoop of the parcel of GCG (genetics computer group). This program calls in the sequence in a GCG format. To find direct repeats we will use the program "repeat". For rcnR and rcnA we found three direct repeats between the -10 box and the translation start of rcnA.We suggest that this is a regulatory region. Based on this, we designed the primers, trying to preserve the regulatory region and changing its promoter.

     

    Primer design.
    The region should be rich in GC, of about 20 nucleotides with a 50% GC content at least and it should finish in G. The program can also show the double chain to facilitate the design of oligo lower. If they are rich in AT, they can be longer primers to increase its Tm.

     

    The most popular program at the center is Oligo. Here we open a new window and paste the sequence. This will open two windows. The first one with the Tm, and the other one with the free energy. The program can calculate all oligos and show potential couples with its parameters. We can also specify were we want the oligo to be located. Once the program generates it, we can analyze its biochemical properties.

    Trying to k Delta G so it won't be lower than -10.


    The differences between the TMS should not be greater than 5 degrees. Enzymes used in PCR use magnesium chloride. The most reliable and processed use magnesium acetate. It is said that 10mM of dinucleotidos is an optimal concentration for PCR, .4 mM is used in the lab. Once we have the oligo, we add a site at the far restraining 5 '. And add nucleotides in the 5 'end to ensure that the enzyme is positioned correctly and efficiently cut. These nucleotides are different for each enzyme, and they also protect the 5' end.

     

    Two plasmids are used as a basis prK415 P. Our advisor, Miguel, already has isolated DNA and this DNA will be used to transform and to have a the plasmid reserved. 2ul of the plasmid and competent cells treated with calcium chloride. The theory says that positive ions are attached to the membrane, so the membrane has a positive charge. As DNA has a negative charge, once they are mixed at 4 degrees Celsius for 20 minutes, we are going to take the tube and put it at 42 degrees centigrade. This stress produces holes in the membrane and many things will be capable or entering or exiting through the membrane, including DNA. Then it remains 2 more minutes at this temperature. The we return it to ice for 5 more minutes to recover. Later, the cells are placed in 1ml of rich medium (LB) were they are allowed to grow at 37 degrees for one hour at 300 revolutions per minute (this allows them to recover).

     

    100ul are taken and used to plate in petri dishes with the antibiotic. It is left to grow for an entire day and at the end, isolated colonies should appear.
    Bacteria with kanamycin 5ml of two strains, one with a deletion in rcnA and another one with any deletion except for rcnA . For 6 hours, the bacteria will have an exponential growth. Genomic DNA will be extracted.

     

    The contents of the tube will be put in an eppendorf, we centrifuge and then we withdraw the liquid medium with a syringe. Before we lyse de cells, we need to wash with TE 10 1 (Tris 10uM EDTA 1uM), with pH 8. Vortex, to separate and disintegrate. Again, we centrifuge and remove supernatant. To lyse, we add 400-450 ul TE5020pH8 and SDS 10% and K proteinase. We leave it at 37 degrees for 20 minutes. The medium goes from an opaque color to a light color when lysis happens. We add ethanol 100% once we have lysed the cells and we vortex. In the presence of ethanol DNA is precipitated, so we add 1ml of ethanol. Then we centrifuge for a few minutes and we have pellet. We wash three times with ethanol 70%, which solubilised salts and the small molecules (including RNA). We remove all the ethanol, this tube is placed in a specific centrifuge. The vacuum from this centrifuge will remove the remain solvent. It is necessary to remove all the ethanol, because this affects the pH. TE 10 1 RNAs 10mg per ml, this Stock solution is divided 1000 times and 50ul approx are added. To check the quality of the DNA extracted, we use an agarose gel.

     

    Transforming bioparts:
    Bacteria needed to extract DNA plasmid. Centrifuge, wash and put solution 1. Glucose, TRIS, EDTA and sometimes RNAs 1. Sodium hydroxide and SDS in the solution 2, sodium hydroxide denatures the DNA. Solution 3 with sodium acetate neutralizes the base. Wash and dry every time.